Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
(Nasdaq: SKYE) (Skye), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced new preclinical data for its novel CB1 antibody, nimacimab
Change Your Life Today For Only $249/month What Should Patients Know About Neck Pain
Popovic DS, Patoulias D, Popovic LS, Karakasis P, Papanas N, Mantzoros CS
Parkes M, Barrett JC, Prescott NJ, Tremelling M, Anderson CA, Fisher SA et al
As the disease progressed, patients would often switch or add therapies to maintain control
US$ 28.52
US$ 26.11
US$ 21.60
